Interventions for Sleep Problems in Early Childhood

Sponsor
Tel-Aviv Sourasky Medical Center (Other)
Overall Status
Unknown status
CT.gov ID
NCT01489215
Collaborator
Israel Science Foundation (Other), U.S. National Science Foundation (U.S. Fed)
180
3

Study Details

Study Description

Brief Summary

This study will inform the field about underlying mechanisms associated with infant sleep problems and will deepen the understanding of the intervention process. The study will provide detailed information on the intervention process itself and will explore how behavioral sleep interventions affect broader infant outcome.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: "presence"
  • Behavioral: "checking"
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
180 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Basic Science
Official Title:
Interventions for Sleep Problems in Early Childhood:The Role of Child, Parental and Intervention Factors
Study Start Date :
Feb 1, 2012
Anticipated Primary Completion Date :
Feb 1, 2015

Arms and Interventions

Arm Intervention/Treatment
Experimental: Clinical group-"presence" intervention

The "Presence" intervention is based on based on the principles of graduated extinction, which has been defined has been defined as "effective and recommended therapy in the treatment of bedtime problems and night wakings" by the Standard of Practice Committee of the American Academy of Sleep Medicine.

Behavioral: "presence"
constant presence of the parent in the child's room throughout the night during the first week of the intervention. In addition to sleeping near the child's crib, the parents repeat the same routines as in the "checking" method if the child is actively protesting or crying.

Experimental: Clinical group-"checking" intervention

The "Checking" training is based on the principles of graduated extinction, which has been defined has been defined as "effective and recommended therapy in the treatment of bedtime problems and night wakings" by the Standard of Practice Committee of the American Academy of Sleep Medicine

Behavioral: "checking"
putting the child into the crib at bedtime and leaving the room with repeated quick visits every 5 minutes if the child is actively protesting or crying, providing brief reassurance, helping the child to resume a sleeping position.

No Intervention: Control Group

Outcome Measures

Primary Outcome Measures

  1. Improved infant sleep [base line to one month follow-up]

    Less parental involvement in falling asleep, less night wakings, heightened sleep efficacy

Secondary Outcome Measures

  1. improvement in infant emotion regulation and in parent-infant interaction [one month follow-up to one year follow-up]

    infant heightened ability to regulate emotion when frustrated, a more secure infant attachment to mother, less infant withdrawal and more maternal sensitivity

Eligibility Criteria

Criteria

Ages Eligible for Study:
9 Months to 18 Months
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • infants at age range 9-18 months;

  • healthy infants with no significant health problems;

  • two-parents families;

  • parents who master the Hebrew language.

  • significant sleep problem lasting more than 3 months:

Our definition for a significant sleep problem in this age range is based on meeting at least one of the following three criteria for the baseline week:

  • an average of three or more night-wakings per night;

  • an average wake period of at least 30 minute per night between sleep onset and morning rise time;

  • more than 30 minutes to fall asleep each night with protests for attention.

Exclusion Criteria:
  • Infants not meeting the inclusion criteria at the baseline assessment will be excluded from the study.

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • Tel-Aviv Sourasky Medical Center
  • Israel Science Foundation
  • U.S. National Science Foundation

Investigators

  • Principal Investigator: Yakov Sivan, Prof., Tel-Aviv Sourasky Medical Center

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Tel-Aviv Sourasky Medical Center
ClinicalTrials.gov Identifier:
NCT01489215
Other Study ID Numbers:
  • TASMC-11-YS-0522-CTIL
First Posted:
Dec 9, 2011
Last Update Posted:
Dec 9, 2011
Last Verified:
Dec 1, 2011
Additional relevant MeSH terms:

Study Results

No Results Posted as of Dec 9, 2011